• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    -NasdaqGS
    10.20 Down 0.38(3.59%) Feb 27, 4:00PM EST
    |After Hours : 10.19 Down 0.01 (0.05%) Feb 27, 4:36PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 3,238   1,466   3,458   10,567  
    Cost of Revenue -   -   -   -  
    Gross Profit 3,238   1,466   3,458   10,567  
    Operating Expenses
    Research Development13,036  11,067  9,183  16,253  
    Selling General and Administrative1,812  2,013  1,588  631  
    Non Recurring -  5  73  17  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (11,610) (11,619) (7,386) (6,334)
    Income from Continuing Operations
    Total Other Income/Expenses Net4,096  (1,805)(1,509)2,147  
    Earnings Before Interest And Taxes(7,514)(13,424)(8,895)(4,187)
    Interest Expense1,217  1,225  1,242  1,242  
    Income Before Tax(8,731)(14,649)(10,137)(5,429)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(8,731)(14,649)(10,137)(5,429)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (8,731) (14,649) (10,137) (5,429)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (8,731) (14,649) (10,137) (5,429)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.